Three months after an opioid use disorder diagnosis, those treated with buprenorphine or methadone had a 76% lower risk of overdose. At 12 months, researchers found a 59% lower risk.
↧
Three months after an opioid use disorder diagnosis, those treated with buprenorphine or methadone had a 76% lower risk of overdose. At 12 months, researchers found a 59% lower risk.